文献速递中药与中成药合理使用

从波斯传入中国的传统药物现状研究

The current status of old traditional medicine introduced from Persia to China.
PubMed 文献 · Front Pharmacol · 2022-09-14

该文基于《本草纲目》记载的1892种药物,梳理其中46种来自波斯(今伊朗)的药物,总结传入时间、中医理论药用价值及中伊现状。发现46种中有20种草药和4种矿石被最新中国药典收载,多数已在中国分布或可替代,但西红花、阿魏、没药和乳香仍高度依赖进口。

要点

  • 西红花、阿魏、没药和乳香仍高度依赖进口,是供应保障的重点品种。
  • 多数波斯来源药物已在中国分布或已有替代品,临床可关注替代使用。

核心结论

  • 《本草纲目》所载46种波斯来源药物中,20种草药和4种矿石被最新中国药典收载为药材。
  • 多数波斯来源药物已在中国分布或有替代品,但西红花、阿魏、没药和乳香仍高度依赖进口。

研究设计与样本

  • 基于《本草纲目》记载的1892种药物,筛选其中46种来自波斯(今伊朗)的药物进行信息汇总。
  • 总结这46种药物的传入时间、中医理论中的药用价值及在中国和伊朗的现状。

主要发现

  • 46种波斯来源药物中,20种草药和4种矿石被最新中国药典收载为药材。
  • 多数草药和矿石已在中国分布或已有替代品可用。
  • 西红花、阿魏、没药和乳香仍高度依赖进口。

关键数值与推荐

  • 《本草纲目》共收载1892种药物,其中46种来自波斯(今伊朗)。

临床怎么用

  • 临床使用波斯来源药物时,可优先考虑已在中国分布或有替代品的品种。
  • 对西红花、阿魏、没药和乳香等仍依赖进口的品种,应关注供应稳定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Traditional Chinese medicine (TCM) includes over ten thousand herbal medicines, some of which were introduced from outside countries and territories. The Silk Road enabled the exchange of merchandise such as teas, silks, carpets, and medicines between the East and West of the Eurasia continent. During this time, the 'Compendium of Materia Medica' (CMM) was composed by a traditional medicine practitioner, Shizhen Li (1,518-1,593) of the Ming Dynasty. This epoch-making masterpiece collected knowledge of traditional medical materials and treatments in China from the 16th century and before in utmost detail, including the origin where a material was obtained. Of 1892 medical materials from the CMM, 46 came from Persia (now Iran). In this study, the basic information of these 46 materials, including the time of introduction, the medicinal value in TCM theory, together with the current status of these medicines in China and Iran, are summarized. It is found that 20 herbs and four stones out of the 46 materials are registered as medicinal materials in the latest China Pharmacopoeia. Now most of these herbs and stones are distributed in China or replacements are available but saffron, ferula, myrrh, and olibanum are still highly dependent on imports. This study may contribute to the further development, exchange, and internationalization of traditional medicine of various backgrounds in the world, given the barriers of transportation and language are largely eased in nowadays.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Shi J, Yang Y, Zhou X, et al. The current status of old traditional medicine introduced from Persia to China. Front Pharmacol. 2022. PMID: 36188609. doi:10.3389/fphar.2022.953352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。